Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.

BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Regularly blowing through a conch shell for six months significantly improved sleep among a small group of people with sleep ...

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...

A reusable product can help save money over the long term. Celikoyar estimates that she was using three tampons every day for ...

President Trump’s effort to lessen crime in Washington, D.C., and launch a “beautification” effort is clashing with a long tradition of Republicans criticizing and outright writing off the ...

CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and ...

WASHINGTON (AP) — President Donald Trump’s tax and spending law will result in less income for the poorest Americans while ...